Synlogic Therapeutics

Developer of drugs using engineered microbes

placeCambridge, Massachusetts, United States calendar_todayFounded 2013 groups85 employees language synlogictx.com

Registered entities

Investor mix

17 investors on record; lead investors include Gates; 1 has since exited.

Investor typeCountShare
Venture capital1271%
Private equity16%
Bank & private debt16%
Other / undisclosed318%
Coming soon